Showing results (171-180 of 236) with videos related to
Sort By:
Pageof 24
Anticancer Research|July 26, 2017
Efficacy In Vitro of Caffeine and Valproic Acid on Patient-Derived Undifferentiated Pleomorphic Sarcoma and Rhabdomyosarcoma Cell LinesKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.Anticancer Research|September 15, 2019
Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse ModelTakashi Higuchi, Norihiko Sugisawa, Kentaro Miyake, et al.Oncotarget|November 5, 2017
Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.Cancer Diagnosis & Prognosis|May 5, 2025
Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)Yohei Asano, Yutaka Yonemura, Chihiro Hozumi, et al.Oncotarget|November 12, 2016
Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) modelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.BMC Musculoskeletal Disorders|February 11, 2019
Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocolAkihiko Takeuchi, Akihiro Nomura, Norio Yamamoto, et al.Cell Cycle (Georgetown, Tex.)|February 1, 2018
Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patientsKei Kawaguchi, Kentaro Igarashi, Tasuku Kiyuna, et al.Cancer Letters|June 22, 2018
Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancerKei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.Cell Cycle (Georgetown, Tex.)|June 17, 2017
Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomideKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.Journal of Cellular Biochemistry|February 9, 2017
High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse ModelKentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.Pageof 24